Caliber Imaging & Diagnostics, Inc., commonly referred to as Caliber ID, is a leading innovator in the field of medical imaging and diagnostics, headquartered in the United States. Founded in 2008, the company has established itself as a key player in the dermatology and oncology sectors, focusing on advanced imaging technologies that enhance disease detection and patient care. Caliber ID's core offerings include state-of-the-art imaging systems and diagnostic tools that utilise proprietary algorithms for improved accuracy and efficiency. Their unique approach to integrating artificial intelligence with imaging solutions sets them apart in a competitive market. With a commitment to advancing healthcare, Caliber ID has achieved significant milestones, including partnerships with major healthcare institutions and recognition for its contributions to early disease detection.
How does Caliber Imaging & Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Caliber Imaging & Diagnostics, Inc.'s score of 44 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Caliber Imaging & Diagnostics, Inc. reported total carbon emissions of approximately 4,995,174,000 kg CO2e. This figure includes Scope 1 emissions of about 19,856,000 kg CO2e, Scope 2 emissions of approximately 2,137,000 kg CO2e (market-based), and significant Scope 3 emissions, which encompass business travel (about 90,776,000 kg CO2e), use of sold products (approximately 3,066,284,000 kg CO2e), purchased goods and services (around 1,511,035,000 kg CO2e), and downstream transportation and distribution (approximately 305,086,000 kg CO2e). In 2022, the company reported total emissions of about 4,000,000,000 kg CO2e, with Scope 1 emissions at approximately 22,518,000 kg CO2e and Scope 2 emissions (market-based) at around 2,383,000 kg CO2e. The Scope 3 emissions for that year included business travel (about 86,399,000 kg CO2e) and use of sold products (approximately 3,898,000,000 kg CO2e). Caliber Imaging & Diagnostics, Inc. has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The company does not appear to inherit emissions data from a parent organisation, indicating that all reported figures are derived directly from their own operations. Overall, while the company has made significant emissions disclosures, there is currently no indication of formal reduction targets or climate pledges in place.
Access structured emissions data, company-specific emission factors, and source documents
2015 | 2020 | 2022 | 2023 | |
---|---|---|---|---|
Scope 1 | 34,896,000 | - | 00,000,000 | 00,000,000 |
Scope 2 | - | 00,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Caliber Imaging & Diagnostics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.